Fintel reports that on May 16, 2025, UBS downgraded their outlook for Iovance Biotherapeutics (NasdaqGM:IOVA) from Buy to ...

I was driving with the window down recently and got a bloodshot eye as a result. It looks terrible, though I’m not in any ...

Merck’s Phase III KEYNOTE-B96 trial shows significant overall and progression-free survival gains with Keytruda plus ...

The PDCO’s positive opinion is based on PolTREG’s original preTreg clinical trial protocol initiated in October 2024, which enrolled children aged 6–16 years in Stage 1 type 1 diabetes. In its ...

Autolus Therapeutics plc (Nasdaq: AUTL), an early commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, announces the online ...

Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy ...

Turnstone Biologics Corp. (“Turnstone” or the “Company”) (Nasdaq-CM: TSBX), a biotechnology company historically focused on the development of a differentiated approach to treat and cure patients with ...

Newly discovered oncology drugs called “DNA-encoded tri-specific T-cell engagers,” or “DTriTEs,” engage the immune system ...

CStone Pharmaceuticals ("CStone", HKEX: 2616), an innovation-driven biopharmaceutical company focused on anti-cancer therapies, announced today that a poster presentation of preclinical data of CS2009 ...

Positive EMA Opinion on Pediatric Investigation Plan for PolTREG's Treg Therapy in Type 1 Diabetes The Paediatric Committee (PDCO) of the European Medicines Agency issues positive ...

That’s why some have balked at the Range Rover Evoque over the years. Originally launched in 2011, with a second generation following in 2018, it’s not really meant to go off-road. Yes ...

According to Number 10, the technology was developed using "learnings from countering Putin's illegal war in Ukraine". Prime Minister Sir Keir Starmer visited defence contractor Leonardo UK in ...